Stay updated on Fremanezumab in Preventing Chronic Migraine Clinical Trial

Sign up to get notified when there's something new on the Fremanezumab in Preventing Chronic Migraine Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fremanezumab in Preventing Chronic Migraine Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The study title changed from “Patients 6 to 17 Years of Age” to “Participants 6 to 17 Years of Age,” the date updated from 2025-01-29 to 2025-10-06, and new metadata sections (Study Identification, Status, Design, Arms and Interventions, Outcome Measures, Eligibility) were added.
    Difference
    2%
    Check dated 2025-10-13T03:09:24.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Major update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.
    Difference
    8%
    Check dated 2025-10-05T17:34:37.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0, indicating a newer version is now in effect.
    Difference
    0.2%
    Check dated 2025-09-28T10:46:23.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.
    Difference
    0.5%
    Check dated 2025-09-14T00:39:12.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.
    Difference
    0.5%
    Check dated 2025-09-06T21:25:22.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, as well as numerous updates to study statuses and contact information. However, several location-related terms and details have been removed.
    Difference
    73%
    Check dated 2025-08-30T15:55:53.000Z thumbnail image

Stay in the know with updates to Fremanezumab in Preventing Chronic Migraine Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fremanezumab in Preventing Chronic Migraine Clinical Trial page.